{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:16:13Z","timestamp":1773288973792,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T00:00:00Z","timestamp":1382400000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s11060-013-1269-1","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T04:37:15Z","timestamp":1382330235000},"page":"407-414","source":"Crossref","is-referenced-by-count":20,"title":["Medical management of Cushing\u2019s disease"],"prefix":"10.1007","volume":"117","author":[{"given":"Nicholas A.","family":"Tritos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly M. K.","family":"Biller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,22]]},"reference":[{"key":"1269_CR1","first-page":"137","volume":"50","author":"H Cushing","year":"1932","unstructured":"Cushing H (1932) The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50:137\u2013195","journal-title":"Bull Johns Hopkins Hosp"},{"issue":"9522","key":"1269_CR2","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","volume":"367","author":"J Newell-Price","year":"2006","unstructured":"Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing\u2019s syndrome. Lancet 367(9522):1605\u20131617","journal-title":"Lancet"},{"issue":"5","key":"1269_CR3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrendo.2011.12","volume":"7","author":"NA Tritos","year":"2011","unstructured":"Tritos NA, Biller BM, Swearingen B (2011) Management of Cushing disease. Nat Rev Endocrinol 7(5):279\u2013289","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"1269_CR4","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","volume":"93","author":"BM Biller","year":"2008","unstructured":"Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M (2008) Treatment of adrenocorticotropin-dependent Cushing\u2019s syndrome: a consensus statement. J Clin Endocrinol Metab 93(7):2454\u20132462","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1269_CR5","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93(5):1526\u20131540","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1269_CR6","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1210\/jc.2003-030461","volume":"88","author":"FG Barker 2nd","year":"2003","unstructured":"Barker FG 2nd, Klibanski A, Swearingen B (2003) Transsphenoidal surgery for pituitary tumors in the United States, 1996\u20132000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 88(10):4709\u20134719","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1269_CR7","doi-asserted-by":"crossref","first-page":"821","DOI":"10.7326\/0003-4819-130-10-199905180-00015","volume":"130","author":"B Swearingen","year":"1999","unstructured":"Swearingen B, Biller BM, Barker FG 2nd, Katznelson L, Grinspoon S, Klibanski A, Zervas NT (1999) Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med 130(10):821\u2013824","journal-title":"Ann Intern Med"},{"issue":"1","key":"1269_CR8","first-page":"63","volume":"83","author":"LS Blevins Jr","year":"1998","unstructured":"Blevins LS Jr, Christy JH, Khajavi M, Tindall GT (1998) Outcomes of therapy for Cushing\u2019s disease due to adrenocorticotropin-secreting pituitary macroadenomas. J Clin Endocrinol Metab 83(1):63\u201367","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1269_CR9","first-page":"3114","volume":"80","author":"D Bochicchio","year":"1995","unstructured":"Bochicchio D, Losa M, Buchfelder M (1995) Factors influencing the immediate and late outcome of Cushing\u2019s disease treated by transsphenoidal surgery: a retrospective study by the European Cushing\u2019s Disease Survey Group. J Clin Endocrinol Metab 80(11):3114\u20133120","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1269_CR10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2265.2002.01511.x","volume":"56","author":"DA Rees","year":"2002","unstructured":"Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF (2002) Long-term follow-up results of transsphenoidal surgery for Cushing\u2019s disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf) 56(4):541\u2013551","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1269_CR11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00006123-200207000-00008","volume":"51","author":"I Shimon","year":"2002","unstructured":"Shimon I, Ram Z, Cohen ZR, Hadani M (2002) Transsphenoidal surgery for Cushing\u2019s disease: endocrinological follow-up monitoring of 82 patients. Neurosurgery 51(1):57\u201361 (discussion 61\u201352)","journal-title":"Neurosurgery"},{"issue":"2","key":"1269_CR12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/jc.2007-2013","volume":"93","author":"CG Patil","year":"2008","unstructured":"Patil CG, Prevedello DM, Lad SP, Vance ML, Thorner MO, Katznelson L, Laws ER Jr (2008) Late recurrences of Cushing\u2019s disease after initial successful transsphenoidal surgery. J Clin Endocrinol Metab 93(2):358\u2013362","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1269_CR13","first-page":"2647","volume":"81","author":"N Sonino","year":"1996","unstructured":"Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M (1996) Risk factors and long-term outcome in pituitary-dependent Cushing\u2019s disease. J Clin Endocrinol Metab 81(7):2647\u20132652","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1269_CR14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3171\/jns.2003.98.5.0967","volume":"98","author":"JC Chen","year":"2003","unstructured":"Chen JC, Amar AP, Choi S, Singer P, Couldwell WT, Weiss MH (2003) Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg 98(5):967\u2013973","journal-title":"J Neurosurg"},{"issue":"12","key":"1269_CR15","first-page":"5695","volume":"86","author":"J Estrada","year":"2001","unstructured":"Estrada J, Garcia-Uria J, Lamas C, Alfaro J, Lucas T, Diez S, Salto L, Barcelo B (2001) The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing\u2019s disease. J Clin Endocrinol Metab 86(12):5695\u20135699","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1269_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2265.1993.tb00975.x","volume":"38","author":"PJ Trainer","year":"1993","unstructured":"Trainer PJ, Lawrie HS, Verhelst J, Howlett TA, Lowe DG, Grossman AB, Savage MO, Afshar F, Besser GM (1993) Transsphenoidal resection in Cushing\u2019s disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf) 38(1):73\u201378","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1269_CR17","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1210\/jc.2012-3200","volume":"98","author":"X Bertagna","year":"2013","unstructured":"Bertagna X, Guignat L (2013) Approach to the Cushing\u2019s disease patient with persistent\/recurrent hypercortisolism after pituitary surgery. J Clin Endocrinol Metab 98(4):1307\u20131318","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1269_CR18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jocn.2010.05.001","volume":"18","author":"SV Liubinas","year":"2011","unstructured":"Liubinas SV, Porto LD, Kaye AH (2011) Management of recurrent Cushing\u2019s disease. J Clin Neurosci 18(1):7\u201312","journal-title":"J Clin Neurosci"},{"issue":"3","key":"1269_CR19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJM199701163360303","volume":"336","author":"J Estrada","year":"1997","unstructured":"Estrada J, Boronat M, Mielgo M, Magallon R, Millan I, Diez S, Lucas T, Barcelo B (1997) The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing\u2019s disease. N Engl J Med 336(3):172\u2013177","journal-title":"N Engl J Med"},{"issue":"2","key":"1269_CR20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1210\/jc.2007-1220","volume":"93","author":"JH Petit","year":"2008","unstructured":"Petit JH, Biller BM, Yock TI, Swearingen B, Coen JJ, Chapman P, Ancukiewicz M, Bussiere M, Klibanski A, Loeffler JS (2008) Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. J Clin Endocrinol Metab 93(2):393\u2013399","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1269_CR21","first-page":"1596","volume":"86","author":"A Vella","year":"2001","unstructured":"Vella A, Thompson GB, Grant CS, van Heerden JA, Farley DR, Young WF Jr (2001) Laparoscopic adrenalectomy for adrenocorticotropin-dependent Cushing\u2019s syndrome. J Clin Endocrinol Metab 86(4):1596\u20131599","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1269_CR22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM195807242590403","volume":"259","author":"DH Nelson","year":"1958","unstructured":"Nelson DH, Meakin JW, Dealy JB Jr, Matson DD, Emerson K Jr, Thorn GW (1958) ACTH-producing tumor of the pituitary gland. N Engl J Med 259(4):161\u2013164","journal-title":"N Engl J Med"},{"issue":"26","key":"1269_CR23","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1056\/NEJMcpc1100919","volume":"365","author":"NA Tritos","year":"2011","unstructured":"Tritos NA, Schaefer PW, Stein TD (2011) Case records of the Massachusetts General Hospital. Case 40-2011. A 52-year-old man with weakness, infections, and enlarged adrenal glands. N Engl J Med 365(26):2520\u20132530","journal-title":"N Engl J Med"},{"issue":"1","key":"1269_CR24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/jc.2006-1328","volume":"92","author":"G Assie","year":"2007","unstructured":"Assie G, Bahurel H, Coste J, Silvera S, Kujas M, Dugue MA, Karray F, Dousset B, Bertherat J, Legmann P, Bertagna X (2007) Corticotroph tumor progression after adrenalectomy in Cushing\u2019s disease: a reappraisal of Nelson\u2019s syndrome. J Clin Endocrinol Metab 92(1):172\u2013179","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1269_CR25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.03082.x","volume":"68","author":"JT Chow","year":"2008","unstructured":"Chow JT, Thompson GB, Grant CS, Farley DR, Richards ML, Young WF Jr (2008) Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing\u2019s syndrome: a review of the Mayo clinic experience. Clin Endocrinol (Oxf) 68(4):513\u2013519","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"69","key":"1269_CR26","first-page":"171","volume":"13","author":"NA Tritos","year":"2012","unstructured":"Tritos NA, Biller BM (2012) Advances in medical therapies for Cushing\u2019s syndrome. Discov Med 13(69):171\u2013179","journal-title":"Discov Med"},{"issue":"10","key":"1269_CR27","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1210\/jc.2006-0997","volume":"91","author":"JW Findling","year":"2006","unstructured":"Findling JW, Raff H (2006) Cushing\u2019s syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab 91(10):3746\u20133753","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"1269_CR28","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJMcp0912025","volume":"362","author":"A Klibanski","year":"2010","unstructured":"Klibanski A (2010) Clinical practice prolactinomas. N Engl J Med 362(13):1219\u20131226","journal-title":"N Engl J Med"},{"issue":"2","key":"1269_CR29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11154-008-9082-4","volume":"10","author":"C Bruin de","year":"2009","unstructured":"de Bruin C, Feelders RA, Lamberts SW, Hofland LJ (2009) Somatostatin and dopamine receptors as targets for medical treatment of Cushing\u2019s syndrome. Rev Endocr Metab Disord 10(2):91\u2013102","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"1269_CR30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jc.2008-1533","volume":"94","author":"R Pivonello","year":"2009","unstructured":"Pivonello R, De Martino MC, Cappabianca P, De Leo M, Faggiano A, Lombardi G, Hofland LJ, Lamberts SW, Colao A (2009) The medical treatment of Cushing\u2019s disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. J Clin Endocrinol Metab 94(1):223\u2013230","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1269_CR31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1530\/EJE-10-0382","volume":"163","author":"A Godbout","year":"2010","unstructured":"Godbout A, Manavela M, Danilowicz K, Beauregard H, Bruno OD, Lacroix A (2010) Cabergoline monotherapy in the long-term treatment of Cushing\u2019s disease. Eur J Endocrinol 163(5):709\u2013716","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1269_CR32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa062222","volume":"356","author":"R Schade","year":"2007","unstructured":"Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E (2007) Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 356(1):29\u201338","journal-title":"N Engl J Med"},{"issue":"3","key":"1269_CR33","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1210\/jc.2009-2095","volume":"95","author":"E Valassi","year":"2010","unstructured":"Valassi E, Klibanski A, Biller BM (2010) Clinical review: potential cardiac valve effects of dopamine agonists in hyperprolactinemia. J Clin Endocrinol Metab 95(3):1025\u20131033","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1269_CR34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMoa054830","volume":"356","author":"R Zanettini","year":"2007","unstructured":"Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G (2007) Valvular heart disease and the use of dopamine agonists for Parkinson\u2019s disease. N Engl J Med 356(1):39\u201346","journal-title":"N Engl J Med"},{"issue":"4","key":"1269_CR35","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/MED.0b013e3283631809","volume":"20","author":"LK Nieman","year":"2013","unstructured":"Nieman LK (2013) Update in the medical therapy of Cushing\u2019s disease. Curr Opin Endocrinol Diabetes Obes 20(4):330\u2013334","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"11","key":"1269_CR36","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1210\/jc.2009-1311","volume":"94","author":"A Ben-Shlomo","year":"2009","unstructured":"Ben-Shlomo A, Schmid H, Wawrowsky K, Pichurin O, Hubina E, Chesnokova V, Liu NA, Culler M, Melmed S (2009) Differential ligand-mediated pituitary somatostatin receptor subtype signaling: implications for corticotroph tumor therapy. J Clin Endocrinol Metab 94(11):4342\u20134350","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1269_CR37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/jc.2008-1008","volume":"94","author":"M Boscaro","year":"2009","unstructured":"Boscaro M, Ludlam WH, Atkinson B, Glusman JE, Petersenn S, Reincke M, Snyder P, Tabarin A, Biller BM, Findling J, Melmed S, Darby CH, Hu K, Wang Y, Freda PU, Grossman AB, Frohman LA, Bertherat J (2009) Treatment of pituitary-dependent Cushing\u2019s disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. J Clin Endocrinol Metab 94(1):115\u2013122","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1269_CR38","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","volume":"366","author":"A Colao","year":"2012","unstructured":"Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BM (2012) A 12-month phase 3 study of pasireotide in Cushing\u2019s disease. N Engl J Med 366(10):914\u2013924","journal-title":"N Engl J Med"},{"key":"1269_CR39","author":"RR Henry","year":"2013","unstructured":"Henry RR, Ciaraldi TP, Armstrong D, Burke P, Ligueros-Saylan M, Mudaliar S (2013) Hyperglycemia associated with pasireotide:results from a mechanistic study in healthy volunteers. J Clin Endocrinol Metab. doi: 10.1210\/jc.2013-1771","journal-title":"J Clin Endocrinol Metab"},{"issue":"4\u20136","key":"1269_CR40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0960-0760(94)90267-4","volume":"49","author":"D Engelhardt","year":"1994","unstructured":"Engelhardt D, Weber MM (1994) Therapy of Cushing\u2019s syndrome with steroid biosynthesis inhibitors. J Steroid Biochem Mol Biol 49(4\u20136):261\u2013267","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"8532","key":"1269_CR41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(87)90222-4","volume":"1","author":"DR McCance","year":"1987","unstructured":"McCance DR, Ritchie CM, Sheridan B, Atkinson AB (1987) Acute hypoadrenalism and hepatotoxicity after treatment with ketoconazole. Lancet 1(8532):573","journal-title":"Lancet"},{"issue":"2","key":"1269_CR42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.1991.tb03517.x","volume":"35","author":"JA Verhelst","year":"1991","unstructured":"Verhelst JA, Trainer PJ, Howlett TA, Perry L, Rees LH, Grossman AB, Wass JA, Besser GM (1991) Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 35(2):169\u2013178","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"1269_CR43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJM197903013000903","volume":"300","author":"JP Luton","year":"1979","unstructured":"Luton JP, Mahoudeau JA, Bouchard P, Thieblot P, Hautecouverture M, Simon D, Laudat MH, Touitou Y, Bricaire H (1979) Treatment of Cushing\u2019s disease by O, p\u2019DDD. Survey of 62 cases. N Engl J Med 300(9):459\u2013464","journal-title":"N Engl J Med"},{"issue":"4","key":"1269_CR44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-12-0358","volume":"167","author":"C Baudry","year":"2012","unstructured":"Baudry C, Coste J, Bou Khalil R, Silvera S, Guignat L, Guibourdenche J, Abbas H, Legmann P, Bertagna X, Bertherat J (2012) Efficiency and tolerance of mitotane in Cushing\u2019s disease in 76 patients from a single center. Eur J Endocrinol 167(4):473\u2013481","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"1269_CR45","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1210\/jc.2011-0536","volume":"96","author":"P Kamenicky","year":"2011","unstructured":"Kamenicky P, Droumaguet C, Salenave S, Blanchard A, Jublanc C, Gautier JF, Brailly-Tabard S, Leboulleux S, Schlumberger M, Baudin E, Chanson P, Young J (2011) Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing\u2019s syndrome. J Clin Endocrinol Metab 96(9):2796\u20132804","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1269_CR46","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1210\/jcem-70-5-1426","volume":"70","author":"HM Schulte","year":"1990","unstructured":"Schulte HM, Benker G, Reinwein D, Sippell WG, Allolio B (1990) Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing\u2019s syndrome and dose-response relationship in normal subjects. J Clin Endocrinol Metab 70(5):1426\u20131430","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1269_CR47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4158\/EP12149.RA","volume":"19","author":"M Fleseriu","year":"2013","unstructured":"Fleseriu M, Molitch ME, Gross C, Schteingart DE, Vaughan TB, Biller BM (2013) A new therapeutic approach in the medical treatment of Cushing\u2019s syndrome: glucocorticoid receptor blockade with Mifepristone. Endocr Pract 19(2):313\u2013326","journal-title":"Endocr Pract"},{"issue":"6","key":"1269_CR48","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","volume":"97","author":"M Fleseriu","year":"2012","unstructured":"Fleseriu M, Biller BM, Findling JW, Molitch ME, Schteingart DE, Gross C (2012) Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing\u2019s syndrome. J Clin Endocrinol Metab 97(6):2039\u20132049","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"1269_CR49","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJMc1000094","volume":"362","author":"RA Feelders","year":"2010","unstructured":"Feelders RA, de Bruin C, Pereira AM, Romijn JA, Netea-Maier RT, Hermus AR, Zelissen PM, van Heerebeek R, de Jong FH, van der Lely AJ, de Herder WW, Hofland LJ, Lamberts SW (2010) Pasireotide alone or with cabergoline and ketoconazole in Cushing\u2019s disease. N Engl J Med 362(19):1846\u20131848","journal-title":"N Engl J Med"},{"issue":"2","key":"1269_CR50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11102-009-0209-8","volume":"13","author":"L Vilar","year":"2010","unstructured":"Vilar L, Naves LA, Azevedo MF, Arruda MJ, Arahata CM, Moura ESL, Agra R, Pontes L, Montenegro L, Albuquerque JL, Canadas V (2010) Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing\u2019s disease. Pituitary 13(2):123\u2013129","journal-title":"Pituitary"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-013-1269-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-013-1269-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-013-1269-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:17:45Z","timestamp":1559348265000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-013-1269-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,22]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["1269"],"URL":"https:\/\/doi.org\/10.1007\/s11060-013-1269-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,22]]}}}